The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Gout, Glucose Metabolism and Obesity: A Case Review

Gout, Glucose Metabolism and Obesity: A Case Review

November 2, 2014 • By Lindsey A. MacFarlane, MD, Daniel H. Solomon, MD, MPH, and Seoyoung C. Kim, MD, ScD, MSCE

  • Tweet
  • Email
Print-Friendly Version / Save PDF

Gout is an inflammatory arthritis associated with hyperuricemia. According to recent data, the prevalence of gout and hyperuricemia in U.S. adults has been increasing over the past 20 years, with current estimates of 3.9% and 21%, respectively.1 New research has put focus on the interplay of hyperuricemia, gout and metabolism. Patients with gout and hyperuricemia contend with a high prevalence of comorbidities, including hypertension, renal disease, obesity, diabetes mellitus (DM) and cardiovascular disease, as well as the metabolic syndrome (MetS).2 In this review, we focus on the association of hyperuricemia and gout with metabolic derangement, including the MetS, DM and obesity.

You Might Also Like
  • Patient Fact Sheet – Gout
  • Bariatric Surgery May Help Obese Patients with Gout, Diabetes
  • Weight Loss Surgery May Reduce Risk of Developing Gout
Explore This Issue
November 2014

Metabolic Syndrome

The MetS, as defined by the 2001 Adult Treatment Panel III criteria, includes abdominal obesity, hypertriglyceridemia, low high-density lipoprotein (HDL) cholesterol, high blood pressure and high fasting glucose. NHANES data estimate the prevalence of the MetS at a striking 22.9%.3 Debate persists as to whether uric acid (UA) has a causative role in the MetS and should be considered in the guidelines, vs. simply being a marker of metabolic derangement.4-6

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Recent evidence from NHANES III demonstrates a graded increase in prevalence of the MetS with higher UA: 18.9% prevalence for UA <6 mg/dL, compared with a prevalence of 70.7% for UA ≥10 mg/dL.7 Even among patients with normouricemia (UA <7 mg/dL in men and <6 mg/dL in women), both the overall prevalence and individual components of the MetS increase with higher UA levels still within the normal range.8 This link between UA and MetS is even noted in children and adolescents as young as 12 years of age.9

The association between UA and the MetS is uncontested, but the cross-sectional nature of these studies makes it difficult to ascertain if UA has a causal role in MetS or is a mere consequence. Several prospective cohort studies sought to shed light on this topic. Sui et al noted a higher rate of incident MetS with increasing UA categories, reporting men in the upper third of UA levels as having 60% higher odds of developing MetS,4 which supports data obtained from both Korean and Chinese populations.6,10 The presence of hyperuricemia prior to MetS onset led the authors to conclude that UA levels predict the risk of MetS. Table 1 outlines selected studies demonstrating the association between increasing UA levels and MetS. Clinically, elevated UA levels may herald MetS; however, further interventional studies would be beneficial to definitively determine whether increased UA directly causes MetS.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Pages: 1 2 3 4 5 6 | Single Page

Filed Under: Conditions, Crystal Arthritis Tagged With: Gout, hyperurecimia, Kim, MacFarlane, metabolism, Research, rheumatologist, rheumatology, SolomonIssue: November 2014

You Might Also Like:
  • Patient Fact Sheet – Gout
  • Bariatric Surgery May Help Obese Patients with Gout, Diabetes
  • Weight Loss Surgery May Reduce Risk of Developing Gout
  • Prevalence of Gout and Hyperuricemia Increase in U.S.

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)